Loading stock data…
$4.21-0.09 (-2.00%)
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. in the Healthcare sector is trading at $4.30 with a market capitalization of $32M. The stock is currently 12% below its 52-week high of $4.90, remaining 19.1% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.78M↑ | $7.68M↓ | $7.84M | — | $7.93M |
| Gross Profit | $6.10M↑ | $6.03M↓ | $6.11M | — | $6.07M |
| Operating Income | $1.20M↑ | $765,134↑ | $392,047 | — | $1.49M |
| Net Income | $554,586↑ | $47,108↑ | -$3.82M | — | $355,785 |
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical co...